Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data.

Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA.

Pigment Cell Melanoma Res. 2009 Apr;22(2):230-4. doi: 10.1111/j.1755-148X.2009.00543.x. Epub 2009 Jan 17.

2.

PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.

LaBerge GS, Bennett DC, Fain PR, Spritz RA.

J Invest Dermatol. 2008 Jul;128(7):1757-62. doi: 10.1038/sj.jid.5701233. Epub 2008 Jan 17.

3.

CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.

Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE.

Pigment Cell Res. 2005 Feb;18(1):55-8.

PMID:
15649153
4.

Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.

Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Nakamura M, Ishibashi H, Ota M; Shinshu PBC Study Group.

J Hepatol. 2010 Sep;53(3):537-41. doi: 10.1016/j.jhep.2010.03.017. Epub 2010 May 25.

PMID:
20557968
5.

Genetic polymorphisms of the T-cell coreceptors CD28 and CTLA-4 in Afro- and Euro-Brazilians.

Pincerati MR, Dalla-Costa R, Pavoni DP, Petzl-Erler ML.

Int J Immunogenet. 2010 Aug;37(4):253-61. doi: 10.1111/j.1744-313X.2010.00917.x. Epub 2010 Apr 30.

PMID:
20477885
6.

Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population.

Jin Y, Birlea SA, Fain PR, Spritz RA.

J Invest Dermatol. 2007 Nov;127(11):2558-62. Epub 2007 Jul 19.

7.

The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease.

Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Nevoral J, Vitek L, Lukas M, Zeniskova I, Cinek O.

BMC Med Genet. 2010 Jun 10;11:91. doi: 10.1186/1471-2350-11-91.

8.

Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.

Misra MK, Pandey SK, Kapoor R, Sharma RK, Agrawal S.

Pharmacogenet Genomics. 2015 Jan;25(1):19-29. doi: 10.1097/FPC.0000000000000102.

PMID:
25356901
9.

Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study.

Li Q, Wang B, Pan F, Zhang R, Xiao L, Guo H, Ma S, Zhou C.

J Gastroenterol Hepatol. 2013 Aug;28(8):1397-402. doi: 10.1111/jgh.12165.

PMID:
23432218
10.

CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.

Sun L, Meng Y, Xie Y, Zhang H, Zhang Z, Wang X, Jiang B, Li W, Li Y, Yang Z.

PLoS One. 2014 Jul 8;9(7):e101986. doi: 10.1371/journal.pone.0101986. eCollection 2014.

11.

Lack of association of functional CTLA4 polymorphisms with juvenile idiopathic arthritis.

Prahalad S, Bohnsack JF, Whiting A, Clifford B, Jorde LB, Guthery SL, Thompson SD, Glass DN, Bamshad MJ.

Arthritis Rheum. 2008 Jul;58(7):2147-52. doi: 10.1002/art.23602.

12.

Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies.

Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta F, Betterle C, De Bellis A, Arnaldi G, Toscano V, Arvat E, Bellastella A, Mantero F, Falorni A; Italian Addison Network.

Eur J Endocrinol. 2010 Feb;162(2):361-9. doi: 10.1530/EJE-09-0618. Epub 2009 Nov 2.

13.

The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.

Song GG, Kim JH, Lee YH.

Mol Biol Rep. 2013 Apr;40(4):2985-93. doi: 10.1007/s11033-012-2370-9. Epub 2012 Dec 24.

PMID:
23264102
14.

Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.

Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H; PBC Study Group in NHOSLJ.

J Gastroenterol. 2011 Oct;46(10):1203-12. doi: 10.1007/s00535-011-0417-7. Epub 2011 May 19.

PMID:
21594562
15.

Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Fain PR, Spritz RA.

J Invest Dermatol. 2011 Feb;131(2):371-81. doi: 10.1038/jid.2010.337. Epub 2010 Nov 18.

16.

CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.

Jones AL, Holliday EG, Mowry BJ, McLean DE, McGrath JJ, Pender MP, Greer JM.

Brain Behav Immun. 2009 Mar;23(3):347-50. doi: 10.1016/j.bbi.2008.09.008. Epub 2008 Sep 26.

PMID:
18848621
17.

Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.

Liang J, Zhang S, Luo Q, Li W, Tian X, Zhang F, Zhao T, Chen X, Zhang X.

Gene. 2015 Sep 1;568(2):196-202. doi: 10.1016/j.gene.2015.05.051. Epub 2015 May 24.

PMID:
26013045
18.

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

N Engl J Med. 2010 May 6;362(18):1686-97. doi: 10.1056/NEJMoa0908547. Epub 2010 Apr 21.

19.

Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.

Megiorni F, Mora B, Maxia C, Gerardi M, Pizzuti A, Rossi A.

Arch Dermatol Res. 2013 Sep;305(7):665-70. doi: 10.1007/s00403-013-1348-3. Epub 2013 Apr 9.

PMID:
23567921
20.

Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade.

Breunis WB, Tarazona-Santos E, Chen R, Kiley M, Rosenberg SA, Chanock SJ.

J Immunother. 2008 Jul-Aug;31(6):586-90. doi: 10.1097/CJI.0b013e31817fd8f3.

Supplemental Content

Support Center